NCI Cancer Bulletin: A Trusted Source for Cancer Research News
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
August 21, 2007 • Volume 4 / Number 24 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document
  • View/Print PDF

The information and links on this page are no longer being updated and are provided for reference purposes only.


70 Years of Excellence in Cancer Research

If Memory Serves...

Several months before the National Cancer Institute Act was passed by Congress and signed by President Roosevelt, Fortune magazine had published an article, "Cancer: the Great Darkness," that pointed out the small amount of money that was being spent for cancer research. (Read more)

For more information about the birth of NCI, go to

Workshop on Phase 0 Trials Slated for September
On September 5, NCI's Division of Cancer Treatment and Diagnosis will sponsor a workshop on "Phase 0 Trials in Oncologic Drug Development" in the Natcher Conference Center on the NIH campus in Bethesda, MD. The goal of the workshop is to define the Phase 0 effort and its potential value, lay out what is needed to perform phase 0 trials, propose ways to evaluate the Phase 0 effort, and determine future research directions for the next 2 to 3 years. Registration and other information can be found at

NCI Director to Open Understanding NCI Teleconference Series
NCI Director Dr. John E. Niederhuber will present an "Update for the Advocacy Community" on September 12 from 1:00-2:00 p.m., EDT, to open the fall "Understanding NCI" teleconference series. Doug Ulman, chair of the NCI Director's Consumer Liaison Group, will address the role advocates play at NCI.

NCI's Office of Liaison Activities (OLA) sponsors the teleconference series, which is intended to inform the advocacy community and the general public about NCI research and scientific initiatives, as well as feature an advocate's perspective on the topic. Callers are encouraged to participate in a discussion with Dr. Niederhuber during the question and answer session.

The teleconference can be accessed toll free within the U.S. at 800-857-6584; the passcode is NCI. Toll-free playback will be available through October 12 at 866-443-8027.

For more information on "Understanding NCI," visit or contact OLA at 301-594-3194 or

NCI Cancer Bulletin Publication Break

The NCI Cancer Bulletin will not be published on August 28 or September 4. We will resume publication on our usual schedule with the September 11 issue.

Breast Cancer Guidelines Now Available in Spanish
The Breast Health Global Initiative's Guidelines for International Breast Health and Cancer Control are now available in Spanish. The guidelines were published in English in 2006 and address resources for early detection and access to care, diagnosis and pathology, treatment and allocation of resources, and health systems and public policy to reduce the burden of breast cancer in low- and middle-income countries (LMCs).

The Spanish-language guidelines are intended to help policymakers and health care providers in Spanish-speaking LMCs improve breast cancer outcomes through evidence-based, economically feasible, and culturally appropriate practices. Russian, Chinese, and Arabic versions of the guidelines are expected soon. The guidelines can be found at